Document is current
Any future updates will be listed below
-
Authors
Muñoz-Montaño, Wendy R.
Cabrera-Galeana, Paula
De la Garza-Ramos, Cynthia
Azim, Hatem A. Jr.
Tabares, Ariana
Perez, Victor
Porras Reyes, Fanny
Sanchez Benitez, Daniel
Alvarado-Miranda, Alberto
Lara-Medina, Fernando
Vazquez Romo, Rafael
Bargallo-Rocha, Enrique
Arrieta, Oscar
Villarreal-Garza, Cynthia https://orcid.org/0000-0003-3587-339X
- License Information
-
More Information
Article History
Received: 4 January 2021
Accepted: 8 April 2021
First Online: 16 June 2021
Declarations
:
: Hatem A. Azim Jr: Consultancy and received honoraria: Nanostring, Novartis; Employment: Innate Pharma. Cynthia Villarreal-Garza: Consultancy or advisory role: Roche, Novartis, Pfizer, Eli Lilly; Speaker honoraria: Roche, Myriad Genetics, Novartis. Dr. Arrieta: Personal fees from Pfizer, grants and personal fees from AstraZeneca, grants and personal fees from Boehringer Ingelheim, personal fees from Lilly, personal fees from Merck, personal fees from Bristol Myers Squibb, grants and personal fees from Roche, outside the submitted work. Other authors: none.
: Ethical approval was obtained from the INCan Ethics Committee (Approval number 0070).
: A waiver was requested due to the retrospective nature of the study.
: A waiver was requested due to the retrospective nature of the study.
